95253 ⎘
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
Nitrogen-containing polycyclic compound and organic electroluminescent device using the same
#3002PRMT5 inhibitors and uses thereof
#3003Antiviral compounds highly effective as HCV-NS5A inhibitor
#3004Macrocyclic proteasome inhibitors
#3005Inhibitors of lysine specific demethylase-1
#3006Pyrimidine compounds and their use as gamma secretase modulators
#3007Indenoindole derivative and organic electroluminescent element
#3008Compound and organic light-emitting device comprising same
#3009Pyrimidine compounds as kinase inhibitors
#30101,3-dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents
#3011Triazole compounds and their use as gamma secretase modulators
#3012PERHYDROQUINOXALINE DERIVATIVES
#3013Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
#3014Pyrimidin-4-yl)oxy)-1h-indole-1-carboxamide derivatives and use thereof
#3015Lanthionine synthetase C-like 2-based therapeutics
#3016Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
#3017Heterocyclic derivates
#3018Therapeutic compounds
#3019Bilaterally-substituted tricyclic compounds for the treatment of human immunodeficiency virus type-1 (HIV-1) infection and other diseases
#3020Histone demethylase inhibitors
#3021Material for organic electroluminescence device and organic electroluminescence device
#3022Compositions useful for treating disorders related to kit
#3023Compounds and compositions for modulating EGFR mutant kinase activities
#3024Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
#3025ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME
#3026Tank-binding kinase inhibitor compounds
#3027Heterocyclic compounds useful for kinase inhibition
#3028Materials for organic electroluminescent devices
#3029Substituted indazole derivatives active as kinase inhibitors
#3030Indolin-2-one or pyrrolo-pyridin/pyrimidin-2-one derivatives
#3031Condensed cyclic compound and organic light-emitting device including the same
#3032Pyrazine derivatives with extended conjugation and methods of using the same in optical applications
#3033Arylquinazolines
#3034Substituted heteroaryl compounds and methods of use thereof
#3035Heterocyclic compounds and use thereof
#3036Therapeutic compounds
#3037NOVEL TETRAZOLONE DERIVATIVES
#3038Diazirine compounds and compositions derived therefrom
#3039Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C
#3040Organic light emitting element
#3041HETEROCYCLIC SUBSTITUTED-3-HETEROARYLIDENYL-2-INDOLINONE DERIVATIVE
#3042Avanafil preparation method
#3043Indazole ureas and method of use
#3044Quinazolinone derivatives useful as FGFR kinase modulators
#3045Pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
#3046Modulators of cellular adhesion
#3047Materials for electronic devices
#3048Inhibitors of leukotriene A4 hydrolase
#3049Thiazoles and uses thereof
#3050Potent and selective inhibitors of hepatitis C virus
#30515-BROMO-INDIRUBINS
#3052Triazolone derivatives or salts thereof and pharmaceutical composition comprising the same
#3053Fused pyrimidine compounds and use thereof
#3054Quinazoline derivatives useful as CB-1 inverse agonists
#3055Hepatitis C virus inhibitors
#3056Compound having diazatriphenylene ring structure, and organic electroluminescent device
#3057Organic electroluminescent materials and devices
#3058Compound for organic optoelectric device, organic light-emitting diode including same, display device including organic light-emitting diode
#3059Electroluminescent Materials Comprising Fluorene Derivatives
#3060Heterocyclic compound for organic electroluminescent device and its application
#3061Biheteroaryl compounds and uses thereof
#3062Substituted 2-azabicycles and their use as orexin receptor modulators
#3063Aminopyrimidinyl compounds
#3064NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND USAGE THEREOF
#3065DIAMINOHETEROARYL SUBSTITUTED INDAZOLES
#3066CC-1065 analogs and their conjugates
#3067Supramolecular aggregates comprising maleimido cores
#30683-HETEROARYL SUBSTITUTED INDAZOLES
#3069C-linked heterocycloaklyl substituted pyrimidines and their uses
#3070Kinase inhibitors and method of treating cancer
#3071Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
#3072MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE AND LIGHTING DEVICE
#3073N-(2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-5-yl)-4-quinazolinamine and N-(2,3-dihydro-1H-indol-5-yl)-4-quinazolinamine derivatives as perk inhibitors
#3074Kinase inhibitors based upon N-alkyl pyrazoles
#3075Inhibitors
#3076Pyrazolylbenzo[d]imidazole derivatives
#30771,2,6-substituted benzimidazoles as flap modulators
#3078METAL NANO-CATALYSTS IN GLYCEROL AND APPLICATIONS IN ORGANIC SYNTHESIS
#3079GLP-1 receptor modulators
#3080PI polyamide
#3081Compositions useful for treating disorders related to kit
#3082NAMPT and ROCK inhibitors
#3083Carboxamide derivatives and use thereof
#3084Alkyl [(S)-1-((S)-2--buta-1,3-diynyl)-phenyl]-1H-imidazol-2-yl}-pyrrolidine-1-carbonyl)-2-methyl-propyl]-carbamate naphthalene-1,5-disulfonate, pharmaceutical composition, medicament, method for treatment of viral diseases
#3085Substituted quinoxalines as FGFR kinase inhibitors
#3086PROTEIN KINASE INHIBITORS
#3087Light-emitting device
#3088Light-emitting element, light-emitting device, electronic device, lighting device, and organic compound
#3089Carrier transport material
#3090Azetidine amide derivatives as orexin receptor antagonists
#3091INDAZOLE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF
#3092Sulfonamide retinoic acid receptor-related orphan receptor modulators and uses thereof
#3093Dimeric compounds
#3094Phosphatidylinositol 3-kinase inhibitors
#30952,5-substituted pyrimidines
#3096BENZIMIDAZOLE RETINOIC ACID RECEPTOR-RELATED ORPHAN RECEPTOR MODULATORS AND USES THEREOF
#3097Heterocyclic compound
#3098Choline kinase inhibitors
#3099Pyrimidine and pyridine compounds and their usage
#3100Intermediates to prepare herbicidal pyrimidone derivatives
#3101Benzamides
#3102SUBSTITUTED AMINO-PYRIMIDINE DERIVATIVES
#3103Substituted pyridizinone derivatives as PDE10 inhibitors
#3104Substituted indol-5-ol derivatives and their therapeutic applications
#31052,5-substituted pyrimidines
#3106Substituted pyrimidine compounds
#3107Organometallic compound and organic light-emitting device including the same
#3108Pyrrolotriazines as potassium ion channel inhibitors
#3109Prodrugs of heteraromatic compounds
#3110GLS1 inhibitors for treating disease
#3111Compounds inhibiting leucine-rich repeat kinase enzyme activity
#31121-substituted, 4-(substituted phenoxymethyl)-1,2,3-triazole compounds with antifungal properties and methods for preparation thereof
#3113Compounds inhibiting leucine-rich repeat kinase enzyme activity
#3114VEGFR3 INHIBITORS
#31152,4-pyrimidinediamine compounds and their uses
#31162,4-pyrimidinediamine compounds and their uses
#3117Pyrimidine carboxamides as sodium channel blockers
#3118Halogen-substituted compounds
#3119Compound for organic electronic element, organic electronic element using the same, and electronic device thereof
#3120PRODRUG FORMS OF KINASE INHIBITORS AND THEIR USE IN THERAPY
#3121Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer
#3122Halogen-substituted compounds
#3123GLS1 INHIBITORS FOR TREATING DISEASE
#3124Pyrimidine-2,4-diamine derivatives for treatment of cancer
#3125Phthalazinone derivatives
#3126Compound for organic electric element, organic electric element comprising the same and electronic device thereof
#3127Flap modulators
#3128Pyridazinone-amides derivatives
#3129Aryl imidazoles and their use as anti-cancer agents
#3130FLAP modulators
#3131Alpha helix mimetics and methods relating thereto
#3132Phosphatidylinositol 3-kinase inhibitors
#3133Phosphatidylinositol 3-kinase inhibitors
#3134Phosphatidylinositol 3-kinase inhibitors
#3135Phosphatidylinositol 3-kinase inhibitors
#3136Phosphatidylinositol 3-kinase inhibitors
#3137Pyrimidinone carboxamide inhibitors of endothelial lipase
#3138PRMT5 inhibitors and uses thereof
#3139LIGHT EMITTING MATERIAL AND ORGANIC LIGHT EMITTING DEVICE USING SAME
#3140Antiaromatic compounds and organic light-emitting devices comprising the same
#3141Condensed fluoranthene compound, organic electroluminescence element material including same, organic electroluminescence element using same, and electronic device
#3142Bicyclic heterocycle compounds and their uses in therapy
#3143Heterocyclic amides as kinase inhibitors
#3144Antiviral compounds
#3145Halogen-substituted pyrazole derivatives as pest-control agents
#3146Bicarbazole derivative, preparation process and use thereof, and organic luminescent device
#3147Organic electroluminescent materials and devices
#3148SUBSTITUTED PORPHYRINS
#3149Solid forms of an antiviral compound
#3150Rho-kinase inhibitors and method of preparation
#3151PKM2 modulators and methods for their use
#3152MATERIALS FOR ELECTRONIC DEVICES
#3153Compounds for electronic devices
#3154Resin composition
#3155Glucokinase activator compounds, compositions containing such compounds, and methods of treatment
#3156COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION
#3157Benzimidazole derivatives as Kinase Inhibitors
#3158Electronic device
#3159Aminopyridine derived compounds as LRRK2 inhibitors
#3160Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors
#3161Halogenated compounds for photodynamic therapy
#3162Materials for electronic devices
#3163Fused heterocyclic compounds as ion channel modulators
#3164Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component
#31652,4-pyrimidinediamine compounds and their uses
#3166Cyanine dye compound and preparation method therefor, and dual-function agent for photodynamic therapy and preparation method therefor
#3167Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
#3168Pyrrolidine derivatives and their use as complement pathway modulators
#3169Hepatitis C virus inhibitors
#3170Crystal forms
#3171Substituted cyanoguanidines as oral anti-virals
#3172Indole carboxamide derivatives as P2X7 receptor antagonist
#3173Guanidine derivatives for the treatment of hepatitis C
#3174Indazole compounds as aldosterone synthase inhibitors
#3175Quinoxaline derivative, and light emitting element, light emitting device, and electronic device using the quinoxaline derivative
#3176Compound and organic electroluminescent device comprising same
#3177Materials for organic electroluminescent devices
#3178Heterocyclic compounds having cholesterol 24-hydroxylase activity
#3179Inhibitors of lysine specific demethylase-1
#3180Disulfur bridge linkers for conjugation of a cell-binding molecule
#3181Use of maleimide derivatives for preventing and treating cancer
#3182Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide
#3183Fused ring compounds as hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof
#3184Bicyclic heterocyclic compound containing a substituted pyrrole ring
#3185Cyclopropyl imidazopyridine PDE10 inhibitors
#3186Cyclobutyl benzimidazoles as PDE 10 inhibitors
#3187Indolinone derivative as tyrosine kinase inhibitor
#3188Use of maleimide derivatives for preventing and treating leukemia
#3189Combustion boiler with pre-drying fuel chute
#3190Pyrazine derivatives as CB2 receptor agonists
#3191Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof
#3192Heteroaryl alkyne compound and use thereof
#3193Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
#3194Compounds for use in the treatment of parasitic diseases
#3195Hepatitis C virus inhibitors
#3196Substituted azines as pesticides
#3197Bicyclic heterocycle compounds and their uses in therapy
#3198INDOLE COMPOUNDS AND THEIR USE AS ANTIMICROBIALS
#3199Substituted indol-5-ol derivatives and their therapeutical applications
#3200Benzoazepine derivative and medical use thereof
#3201Indole derivatives and use thereof
#3202Isothiazole derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof
#3203Pyrimidine derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof
#3204Secondary alcohol substituted triazoles as PDE10 inhibitors
#3205Pyridine derivatives as PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof
#3206Thermally activated delayed fluorescence material, a method of synthesizing the same and an OLED device using the same
#3207Substituted heteroaryl compounds and methods of use
#3208Inhibitors of cytomegalovirus
#3209Tropomyosin-related kinase (TRK) inhibitors
#32101,2-disubstituted heterocyclic compounds
#3211Substituted heteroaryl compounds and methods of use
#3212Substituted heteroaryl compounds and methods of use
#32134-carboxamido-isoindolinone derivatives as selective PARP-1 inhibitors
#32141 H-pyrazole and 4,5-disubstituted thiazole inhibitors of SYK
#3215Bicyclic heterocycle compounds and their uses in therapy
#3216Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators
#3217RORγ modulators
#32182,4-pyrimidinediamine compounds and their uses
#3219(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
#3220RSV antiviral compounds
#3221Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity
#3222Bicyclic heterocycle compounds and their uses in therapy
#3223FLAP modulators
#3224Five-membered heterocycles useful as serine protease inhibitors
#3225Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
#3226Pyridine compounds and the uses thereof
#32277-hydroxy-indolinyl antagonists of P2Yreceptor
#3228Substituted pyrimidine compound and uses thereof
#3229Orexin receptor antagonists which are [bi-(hetero-)aryl]-[2-(bi-(hetero-)aryl)-pyrrolidin-1-yl]-methanone derivatives
#32304-(INDOLYL OR BENZIMIDAZOLYL)AMINO-2-(2-(INDOL-3-YL)ETHYL)AMINOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER
#3231Rho kinase inhibitors
#3232Flap modulators
#3233NOVEL COMBINATION OF A HOST COMPOUND AND A DOPANT COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME
#3234Biscarbazole derivative and organic electroluminescent element using same
#3235MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES
#3236Pyridinones
#3237INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#32382,4-disubstituted pyrimidine compounds useful as kinase inhibtors
#3239Biscarbazole derivative host materials and green emitter for OLED emissive region
#3240MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES
#3241Compounds for treating papilloma virus infection
#3242Phosphonate compounds for treatment of complement mediated disorders
#3243Ether compounds for treatment of complement mediated disorders
#3244Carbamate, ester, and ketone compounds for treatment of complement mediated disorders
#3245Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders
#3246Amino compounds for treatment of complement mediated disorders
#3247Amide compounds for treatment of complement mediated disorders
#3248Process for the preparation of vilazodone hydrochloride and its amorphous form
#3249Alkyne compounds for treatment of complement mediated disorders
#3250Compounds for treatment of complement mediated disorders
#3251Factor D inhibitors useful for treating inflammatory disorders
#3252Compound and organic electroluminescence device comprising same
#3253SPIRO RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS
#3254Bicyclic substituted pyrimidine compounds
#3255Benzopiperazine compositions as BET bromodomain inhibitors
#3256ANTI-VIRAL COMPOUNDS
#3257SUBSTITUTED PYRIMIDINYL-AMINES AS PROTEIN KINASE INHIBITORS
#3258BISCARBAZOLE DERIVATIVE, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME
#3259Condensed fluoranthene compound, material for organic electroluminescent element using this compound, organic electroluminescent element using this material, and electronic device
#3260Pyrimidines as novel therapeutic agents
#3261Heterocyclic compounds and uses thereof
#3262INSECTICIDAL TRIAZINONE DERIVATIVES
#3263VEGFR3 INHIBITORS
#3264Cyclopropylamines as LSD1 inhibitors
#32654-INDAZOLYLAMINO-2-(2-(INDOL-3-YL)ETHYL)AMINOPYRIMIDINES USEFUL FOR THE TREATMENT OF CANCER
#3266KINASE INHIBITORS
#3267Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
#3268Modified carbocyanine dyes and their conjugates
#3269Anti-Viral Compounds
#3270Compositions of protein receptor tyrosine kinase inhibitors
#3271Phosphatidylinositol 3-kinase inhibitors
#3272Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
#3273Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
#3274Materials for organic electroluminescent devices
#3275Inhibitors of bruton's tyrosine kinase
#3276Heterocyclic modulators of lipid synthesis
#3277Uracil derivatives as AXL and c-MET kinase inhibitors
#3278Compounds for the treatment of associated disease
#32792,3-benzodiazepines
#3280Pyrazole derivatives as p38 MAP inhibitors
#3281SOLID FORMS COMPRISING INHIBITORS OF HCV NS5A, COMPOSITIONS THEREOF, AND USES THEREWITH
#3282Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis
#3283Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug
#32844-aminoquinazolinyl-2-yl-1-pyrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors
#3285Compounds and compositions for modulating EGFR Activity
#3286Polyamide compound and pharmaceutical composition for treating mitochondrial genetic disease
#3287Tetrazole-substituted arylamides as P2Xand P2Xantagonists
#3288Azaindole derivatives
#3289PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS
#3290Pyrazolyl derivatives as Syk inhibitors
#3291Pyrrolidine derivatives and their use as complement pathway modulators
#3292Carbazole compound and organic light-emitting device including the same
#3293TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
#3294FAAH inhibitors
#3295Imidazolyl analogs as syk inhibitors
#3296Use of certain manganese-accumulating plants for carrying out organic chemistry reactions
#3297Substituted 2-azabicycles and their use as orexin receptor modulators
#3298Novel Organic Electroluminescent Compounds and Organic Electroluminescent Device Using The Same
#3299Carbazole compound and organic light-emitting device including the same
#3300Novel Organic Electroluminescent Compounds and Organic Electroluminescent Device Using The Same